The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6664022 7012346 F 6664022-2 20100329 20100401 EXP A0788541A GLAXOSMITHKLINE YR M Y 104.5 KG 20100401 CN UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6664022 1013430826 PS AVANDIA 1 ORAL 4MG TWICE PER DAY 021071

Indications of drugs used

Event ID DRUG SEQ INDI PT
6664022 1013430826 TYPE 2 DIABETES MELLITUS

Outcome of event

Event ID OUTC COD
6664022 HO

Reactions reported

Event ID PT
6664022 CHEST PAIN
6664022 CORONARY ARTERY DISEASE
6664022 DYSPNOEA
6664022 ECONOMIC PROBLEM
6664022 PAIN
6664022 SURGERY
6664022 UNEVALUABLE EVENT

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6664022 1013430826 20030101 20060101